EFG Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-39,205
Closed -$2.63M 184
2024
Q3
$2.63M Buy
39,205
+7,400
+23% +$608K 0.44% 90
2024
Q2
$3.61M Sell
31,805
-2,595
-8% -$328K 0.62% 42
2024
Q1
$4.77M Sell
34,400
-844
-2% -$106K 0.82% 28
2023
Q4
$4.37M Sell
35,244
-4,183
-11% -$427K 0.83% 29
2023
Q3
$3.68M Sell
39,427
-1,894
-5% -$214K 0.87% 38
2023
Q2
$5.31M Sell
41,321
-7,710
-16% -$933K 1.14% 16
2023
Q1
$5.7M Sell
49,031
-10,720
-18% -$1.2M 1.26% 14
2022
Q4
$6.7M Sell
59,751
-4,463
-7% -$490K 1.5% 10
2022
Q3
$5.17M Sell
64,214
-5,728
-8% -$485K 1.2% 22
2022
Q2
$5.21M Buy
69,942
+8,870
+15% +$810K 1.1% 26
2022
Q1
$7.81M Buy
61,072
+4,548
+8% +$497K 1.17% 27
2021
Q4
$7.59M Buy
+56,524
New +$8.12M 0.99% 35

Other funds holding DXCM

EFG Asset Management's DXCM Position: Q4 2024 in Review

EFG Asset Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 39,205 shares — an estimated $2.63M sold.

EFG Asset Management first reported a position in DXCM in Q4 2021 and held it in 12 quarters. The position peaked at $7.81M in Q1 2022. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • EFG Asset Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • EFG Asset Management sold 39,205 DexCom shares in Q4 2024, an estimated $2.63M.
  • EFG Asset Management first reported a position in DexCom in Q4 2021 and held it in 12 quarters.
  • EFG Asset Management's DexCom position peaked at $7.81M in Q1 2022.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on EFG Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.